Nurse Practitioner, Psychiatric/Mental Health · Council Bluffs, IA
NPI
1598786097
Since 2006
Specialty
Nurse Practitioner, Psychiatric/Mental Health
Code 363LP0808X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
801 Harmony St, Suite 302
Council Bluffs, IA, 51503
Phone (712) 328-2609
Groups this clinician bills Medicare through
Medicare paid, 2024
$58K
1,660 services
Medicare patients, 2024
147
Average age 58
Drug cost, 2024
$2.6M
7,758 prescriptions
Company payments, 2025
$716
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stephanie R Gray was code 96127 (behavioral health services), 483 times for 130 patients. In total Stephanie R Gray billed 1,660 services in 9 codes, and Medicare paid $58K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-04-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 96127 Behavioral Health Services | Office | 483 | 130 | $2.86 | $1,381 |
| 99213 Office E&M - Established | Office | 367 | 127 | $49.03 | $18K |
| 99214 Office E&M - Established | Office | 178 | 81 | $71.48 | $13K |
| 90833 Psychotherapy - Nongroup | Office | 145 | 68 | $43.67 | $6,332 |
| 90792 Psychotherapy - Nongroup | Office | 16 | 16 | $115.79 | $1,853 |
By year: 2022 $68K for 1,836 services; 2023 $62K for 1,772 services; 2024 $58K for 1,660 services.
Medicare prescription drug claims, 2024
In 2024, the drug Stephanie R Gray prescribed most often to Medicare patients was Quetiapine Fumarate, with 378 prescriptions and refills. In total Stephanie R Gray wrote 7,758 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Quetiapine Fumarate Generic | 378 | 422 | 38 | $17K |
| Clozapine Generic | 316 | 316 | 14 | $18K |
| Mirtazapine Generic | 283 | 299 | 35 | $1,786 |
| Lorazepam Generic | 251 | 251 | 31 | $1,719 |
| Trazodone Hcl Generic | 249 | 258 | 33 | $1,659 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 246 | 315 | 25 | $2,542 |
| Olanzapine Generic | 241 | 243 | 30 | $17K |
| Benztropine Mesylate Generic | 229 | 242 | 29 | $1,614 |
| Clonazepam Generic | 206 | 209 | 28 | $1,167 |
| Aripiprazole Generic | 199 | 242 | 38 | $7,869 |
| Duloxetine Hcl Generic | 181 | 248 | 29 | $2,944 |
| Risperidone Generic | 175 | 176 | 21 | $1,771 |
| Trintellix Vortioxetine Hydrobromide | 169 | 195 | 24 | $91K |
| Buspirone Hcl Generic | 166 | 180 | 20 | $5,481 |
| Prazosin Hcl Generic | 159 | 165 | 18 | $1,514 |
Brand drugs: - claims; generic drugs: 6,653 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stephanie R Gray $716 ($716 in general payments such as food, travel and fees) from 14 companies. The largest payer was Teva Pharmaceuticals USA, Inc. with $228.
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. TEVA | 13 | $228 |
| Janssen Pharmaceuticals, Inc JNJ | 10 | $140 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $64.52 |
| Neurocrine BioSciences, Inc. NBIX | 3 | $57.71 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 3 | $49.13 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $33.78 |
| Alkermes, Inc. ALKS | 1 | $24.89 |
| Luye Pharma (USA) Ltd. 2186.HK | 1 | $23.29 |
| Abbvie Inc. ABBV | 1 | $19.32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 1 | $18.84 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.